Legal Opinion
Senju Pharmaceutical Co. v. Apotex Inc.
District Court, D. Delaware
Decided September 17, 2012No. Civil No. 11-1171-SLRPublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
Senju Pharmaceutical Co., Ltd. (“Senju”) and Kyorin Pharmaceutical Co., Ltd. (“Kyorin”) are co-owners of United States Patent No. 6,333,045 (“the '045 patent”), which is directed to aqueous liquid pharmaceutical compositions comprising gatifloxacin and disodium edetate, as well as various methods utilizing these compositions. Allergan, Inc. (“Allergan”) is the exclusive licensee of the '045 patent for ophthalmic uses and the holder of two New Drug Applications (“NDAs”) that cover gatifloxacin ophthalmic solutions. (D.I. 1 at ¶¶…
2Cases cited21 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Montana v. United StatesSupreme Court of the United States · 1979
16 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Senju Pharmaceutical Co. v. Apotex Inc.Court of Appeals for the Federal Circuit · 2014
- Senju Pharmaceutical Co. v. Lupin LimitedCourt of Appeals for the Federal Circuit · 2015
- Apotex, Inc. v. Senju Pharmaceutical Co.District Court, D. Delaware · 2013
- Senju Pharmaceutical Co. v. Apotex Inc.Court of Appeals for the Federal Circuit · 2014
- Senju Pharmaceutical Co. v. Apotex Inc.Court of Appeals for the Federal Circuit · 2014
1 more not listed; retrieve them via the Exa API.